Among these primary pancreatic, liver and lung metastatic tumors, the frequencies of positive APLP2 expression were 66.66% (16/24), 52.17% (12/23), and 100% (1/1), respectively. The gene discussed is APLP2; the disease is metastatic neoplasm.